03.07.2024 08:04:15 - dpa-AFX: *GSK ACQUIRES FULL RIGHTS TO MRNA CANDIDATE VACCINES FOR INFLUENZA AND COVID-19; CUREVAC RECEIVES UP TO EUR 1.45 BLN

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GSK PLC LS-,3125 A3DMB5 Xetra 18,570 29.07.24 10:55:40 +0,155 +0,84% 18,560 18,595 18,415 18,415

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH